Optimised dosing of antibiotics: understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring

Event Description

In the field of antimicrobial therapy, achieving optimal dosing of antibiotics is essential to ensure effective treatment outcomes while minimizing the risk of adverse effects and antimicrobial resistance. This course aims to provide participants with a comprehensive understanding of pharmacokinetics/pharmacodynamics (PK/PD) principles, strategies for setting clinical breakpoints, individualized dosing approaches, and the role of therapeutic drug monitoring (TDM) in optimizing antibiotic therapy.

Intended audience:  

Participants of the ESCMID AMS Certificate program, specialists in infectious diseases, intensive care specialists, clinical microbiologists, pharmacologists and pharmacists.

Objectives: 

This course presents and summarizes currently available knowledge on PK/PD of commonly used antibiotics and antivirals, strategies for setting clinical breakpoints, individualised dosing, and therapeutic drug monitoring. The aim is to provide participants with insights that can be used to optimise antibiotic therapy for different patient groups, infection sites and pathogens. Further state of the art and innovative approaches for antimicrobial drug development will be highlighted.

Course coordinator: 

Thomas Tängdén, Sweden 
Birgit Koch, The Netherlands
Sonia Luque Pardos, Spain
Sebastian Wicha, Germany
Markus Zeitlinger, Austria  

Organisers:  

ESCMID PK/PD of Anti-Infectives Study Group (EPASG)

Accreditation: 

ESCMID office will apply for EACCME accreditation. 

Certification: 

Course organisers will monitor attendance. Only participants attending live sessions will be able to receive the certification.

Registration details: 

This course is part of the AMS Certificate Programme, but has some spaces open to registrations outside of the programme.

Registration fees include full access to the online course.  

Downloads

• Programme

Registration Fees